Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

M Asano, M Toda, N Sakaguchi, S Sakaguchi, M Asano, M Toda, N Sakaguchi, S Sakaguchi

Abstract

Neonatal thymectomy (NTx), especially around day 3 after birth, causes various organ-specific autoimmune diseases in mice. This report shows that: (a) T cells expressing the interleukin 2 receptor alpha chains (CD25) ontogenically begin to appear in the normal periphery immediately after day 3, rapidly increasing within 2 wk to nearly adult levels (approximately 10% of CD3+ cells, especially of CD4+ cells); (b) NTx on day 3 eliminates CD25+ T cells from the periphery for several days; inoculation immediately after NTx of CD25+ splenic T cells from syngeneic non-Tx adult mice prevents autoimmune development, whereas inoculation of CD25- T cells even at a larger dose does not; and furthermore, (c) similar autoimmune diseases can be produced in adult athymic nu/nu mice by inoculating either spleen cell suspensions from 3-d-old euthymic nu/+ mice or CD25+ cell-depleted spleen cell suspensions from older, even 1-yr-old, nu/+ mice. The CD25- populations from neonates or adults are also similar in the profile of cytokine formation. These results, taken together, indicate that one aspect of peripheral self-tolerance is maintained by CD25+ T cells that sustain potentially pathogenic self-reactive T cells in a CD25- dormant state; the thymic production of the former is developmentally programmed to begin on day 3 after birth in mice. Thus, NTx on day 3 can, at least transiently, eliminate/reduce the autoimmune-preventive CD25+ T cells, thereby leading to activation of the self-reactive T cells that have been produced before NTx.

References

    1. J Exp Med. 1967 May 1;125(5):947-66
    1. Am J Pathol. 1987 Feb;126(2):303-14
    1. Science. 1974 Apr 12;184(4133):162-3
    1. Lab Invest. 1976 Jun;34(6):550-7
    1. Lab Invest. 1980 Apr;42(4):387-95
    1. Immunol Rev. 1979;47:63-90
    1. Proc Natl Acad Sci U S A. 1980 May;77(5):2890-4
    1. Diabetologia. 1987 Jan;30(1):22-6
    1. Anal Biochem. 1987 Apr;162(1):156-9
    1. J Immunol. 1988 Jul 1;141(1):105-13
    1. J Immunol. 1989 Jan 15;142(2):471-80
    1. J Exp Med. 1989 May 1;169(5):1669-80
    1. Eur J Immunol. 1989 Apr;19(4):617-23
    1. J Exp Med. 1989 Jun 1;169(6):2149-58
    1. Science. 1989 Aug 18;245(4919):749-52
    1. J Exp Med. 1990 Aug 1;172(2):537-45
    1. J Exp Med. 1990 Nov 1;172(5):1277-85
    1. J Exp Med. 1990 Dec 1;172(6):1701-8
    1. Cell. 1990 Dec 21;63(6):1249-56
    1. Nature. 1991 Jun 6;351(6326):482-5
    1. Annu Rev Immunol. 1991;9:193-217
    1. Immunol Rev. 1991 Oct;123:115-44
    1. Immunol Rev. 1991 Oct;123:37-64
    1. Immunology. 1991 Nov;74(3):524-32
    1. Autoimmunity. 1992;12(1):69-70
    1. J Immunol. 1992 Sep 15;149(6):2212-8
    1. Eur J Immunol. 1993 Apr;23(4):809-14
    1. J Exp Med. 1993 Aug 1;178(2):419-26
    1. Autoimmunity. 1993;15(2):155-61
    1. J Immunol. 1994 Feb 1;152(3):1471-84
    1. J Immunol. 1994 Feb 15;152(4):1509-14
    1. Int Immunol. 1994 Aug;6(8):1257-64
    1. Immunol Today. 1995 Feb;16(2):61-7
    1. J Immunol. 1995 Aug 1;155(3):1151-64
    1. J Autoimmun. 1996 Apr;9(2):211-20
    1. J Exp Med. 1982 Dec 1;156(6):1577-86
    1. J Immunol. 1983 Nov;131(5):2445-51
    1. J Immunol. 1984 Oct;133(4):1970-5
    1. J Exp Med. 1985 Jan 1;161(1):72-87
    1. Clin Exp Immunol. 1980 Jun;40(3):540-53
    1. J Immunol. 1981 Dec;127(6):2496-501
    1. Immunogenetics. 1981;14(1-2):15-27
    1. Clin Exp Immunol. 1981 Nov;46(2):425-34
    1. J Exp Med. 1982 Dec 1;156(6):1565-76
    1. Fed Proc. 1985 Oct;44(13):2874-81
    1. J Immunol. 1985 Dec;135(6):3988-94
    1. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374-8
    1. Am J Pathol. 1987 Feb;126(2):293-302
    1. J Immunol. 1970 Jan;104(1):54-62

Source: PubMed

3
订阅